Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
15.10
-0.24 (-1.56%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Employees
Takeda Pharmaceutical Company had 47,455 employees as of March 31, 2025. The number of employees decreased by 1,826 or -3.71% compared to the previous year.
Employees
47,455
Change (1Y)
-1,826
Growth (1Y)
-3.71%
Revenue / Employee
$654,374
Profits / Employee
$19,999
Market Cap
47.48B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
Mar 31, 2024 | 49,281 | 186 | 0.38% |
Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
Mar 31, 2022 | 47,347 | 248 | 0.53% |
Mar 31, 2021 | 47,099 | -396 | -0.83% |
Mar 31, 2020 | 47,495 | -2,083 | -4.20% |
Mar 31, 2019 | 49,578 | 22,348 | 82.07% |
Mar 31, 2018 | 27,230 | -2,670 | -8.93% |
Mar 31, 2017 | 29,900 | -1,268 | -4.07% |
Mar 31, 2016 | 31,168 | -160 | -0.51% |
Mar 31, 2015 | 31,328 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TAK News
- 2 days ago - Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit - Business Wire
- 5 days ago - Takeda Pharmaceutical Company Limited (TAK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 days ago - Takeda Pharmaceutical Company Limited (TAK) Oveporexton (TAK-861) Investor Call On Phase 3 Narcolepsy Type 1 Data Presented At World Sleep 2025 (Transcript) - Seeking Alpha
- 6 days ago - Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025 - Business Wire
- 8 days ago - U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease - Business Wire
- 22 days ago - What's Going On With Takeda Stock On Friday? - Benzinga
- 24 days ago - Japan's Takeda weighs India for global trials to speed up drug launches - Reuters
- 5 weeks ago - Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis - Newsfile Corp